Drugs / Sodium Ferric Gluconate complex in sucrose
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE | — | 2011-03-31 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00224042 | Apr 2003 → May 2005 | chronic renal failure syndrome, iron deficiency anemia | Watson Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Ferric Gluconate complex in sucrose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00224042 ↗ |
| Route | Intravenous | “Sodium ferric gluconate complex in sucrose, 250 mg IV weekly for 4 doses” NCT00224042 ↗ |